Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals Post author:Sam Post published:February 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Biogen Release: Company Reports 2016 Revenues Of $11.4 Billion January 25, 2017 Why AbbVie Could Join the M&A Mania Soon January 30, 2018 Medtronic RESOLUTE ONYX 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year May 17, 2017
Medtronic RESOLUTE ONYX 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year May 17, 2017